U.S. markets closed

Look at American Century Ultra Investor Fund (TWCUX)

Zacks Equity Research

American Century Ultra Investor Fund (TWCUX) seeks long-term capital growth. This domestic equity fund mainly invests in broad range of mid to large-sized companies exhibiting strong growth. TWCUX looks for stocks of companies they believe will increase in value over time, using a growth investment strategy developed by American Century. TWCUX's investment decisions are based primarily on the business fundamentals of the individual companies. TWCUX invests in U.S as well as foreign companies. Most of the foreign investments are in companies located and doing business in developed countries.

This Large Growth product has a history of positive total returns for over 10 years.  Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 7.6% and 5 year 13.2%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.

TWCUX’s performance, as of the last filing, when compared to funds in its category was in the top 47% over the past 1 year, in the top 30% over the past 3 years, and in the 43% over the past 5 years.

The American Century Ultra Investor fund, as of the last filing, allocates their fund in two major groups; Large Growth and Small Growth. Further, as of the last filing, Apple Inc, Alphabet Inc and Amazon.com Inc were the top holdings for TWCUX.

This Zacks Rank #2 (Buy) was incepted in November 1981 and is managed by American Cent. TWCUX carries an expense ratio of 0.98% and requires a minimal initial investment of $2,500.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>


View All Zacks #1 Ranked Mutual Funds
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Get Your Free (TWCUX): Fund Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research